EU countries
| (n = 18) | (n = 17) |
Constant (α) | 7.95 (7.49 to 8.40) | 7.87 (7.28 to 8.45) |
GDP-PPP-adjusted price | −0.49 (−1.07 to 0.09) | −0.43 (−1.07 to 0.21) |
Male to female prevalence ratio | | 0.14 (−0.33 to 0.62) |
Other countries
| (n = 12) | (n = 11) |
Constant (α) | 8.38 (7.68 to 9.09) | 8.42 (7.61 to 9.24) |
GDP-PPP adjusted price | −1.00 (−1.57 to −0.42) | −0.87 (−1.67 to −0.07) |
Male to female prevalence ratio | | −0.12 (−0.44 to 0.20) |
GDP-PPP ⩾15000US$
| (n = 19) | (n = 18) |
Constant (α) | 8.16 (7.73 to 8.59) | 8.12 (7.57 to 8.68) |
GDP-PPP adjusted price | −0.79 (−1.30 to −0.28) | −0.76 (−1.34 to −0.19) |
Male to female prevalence ratio | | 0.10 (−0.39 to 0.58) |
GDP-PPP <15000US$
| (n = 11) | (n = 10) |
Constant (α) | 8.29 (7.56 to 9.01) | 8.28 (7.60 to 8.97) |
GDP-PPP adjusted price | −0.90 (−1.51 to −0.29) | −0.41 (−1.23 to 0.41) |
Male to female prevalence ratio | | −0.34 (−0.72 to 0.04) |